Epidemiology of psoriatic arthritis in the population of the United States.

By J. Gelfand, D. Gladman, P. Mease, Nana Smith, D. Margolis, T. Nijsten, R. Stern, S. Feldman, T. Rolstad. Journal of American Academy of Dermatology, 2005

607 citations recorded by the source corpus.

Subfields: Immunology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/4bd5f427ab736be32d627424453f99eacd067da1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. Andrea B. Troxel
2. J. Gelfand
3. M. Lebwohl

In Rheumatology

1. Andrea B. Troxel
2. J. Gelfand

Citations in the corpus

• Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. (2008, background): “25%.(2) In a recent large clinical trial with more than 1000 patients, 84% of patients with PsA had cutaneous manifestations for an average of 12 years before the onset of PsA.”
• The risk of depression, anxiety and suicidality in patients with psoriasis: A population-based cohort study (2010, background): “tors and results in chronic T helper (TH)1 and TH17 inflammation in the skin, blood, and in some patients, joints.(5,6)”